Atelerix

https://atelerixlifesciences.com/

About

Atelerix is a preclinical biotech company developing a platform technology of novel small molecules targeting unmet medical needs arising from the opioid crisis.

LinkedIn
Facebook

Sector

Clinical Research

Company Stage

Development

Sector

Clinical Research

Company Stage

Development

Twitter
Linked In

Connect
Cookie Policy (US)
Privacy Statement (US)
Disclaimer

Manage Cookie Consent

We use cookies to optimize our website and our service.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Preferences

{title} {title} {title}

Atelerix

About

Sector

Company Stage

Related News

Novel Small Molecule Technology Reverses Life-Threatening Opioid-Induced Respiratory Depression

Sector

Company Stage